RETRACTION: LncRNA SNHG19 Promotes the Development of Non-Small Cell Lung Cancer via Mediating miR-137/E2F7 Axis (Retraction of Vol 11, art no 630241, 2021)

被引：0

|

作者：

Zhao, G. Y.

Ning, Z. F.

Wang, R.

机构：

来源：

FRONTIERS IN ONCOLOGY | 2021年 / 11卷

关键词：

D O I：

10.3389/fonc.2021.840907

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页数：1

相关论文

共 50 条

[21] RETRACTION: KDM4A promotes the growth of non-small cell lung cancer by mediating the expression of Myc via DLX5 through the Wnt/β-catenin signaling pathway (Retraction of Vol 262, art no 118508, 2020)
Sun, Shanshan
Yang, Fujun
Zhu, Yongcun
Zhang, Shukun
LIFE SCIENCES, 2022, 306
[22] RETRACTION: The LMCD1-AS1/miR-526b-3p/OSBPL5 axis promotes cell proliferation, migration and invasion in non-small cell lung cancer (Retraction of Vol 22, art no 30, 2022)
Hu, Rui
Yu, Yankai
Wang, Haining
BMC PULMONARY MEDICINE, 2023, 23 (01)
[23] RETRACTION: miR-215 functions as a tumor suppressor and directly targets ZEB2 in human non-small cell lung cancer (Retraction of Vol 10, art no 1985, 2015)
Hou, Yan
Zhen, Junwen
Xu, Xiaodong
Zhen, Kun
Zhu, Bin
Pan, Rui
Zhao, Chidong
ONCOLOGY LETTERS, 2021, 22 (02)
[24] RETRACTION: Repression of lncRNA-SVUGP2 mediated by EZH2 contributes to the development of non-small cell lung cancer via brisking Wnt/β-catenin signal (Retraction of Vol 47, Pg 3400, 2019)
Wei, Sen
Liu, Jinghao
Li, Xin
Liu, Xingyu
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2022, 50 (01) : 81 - 81
[25] RETRACTION: Long noncoding RNA HOXA-AS2 promotes non-small cell lung cancer progression by regulating miR-520a-3p (Retraction of Vol 39, art no BSR20190283, 2019)
不详
BIOSCIENCE REPORTS, 2022, 42 (10)
[26] RETRACTION: lncRNA MRUL Suppressed Non-Small Cell Lung Cancer Cells Proliferation and Invasion by Targeting miR-17-5p/SRSF2 Axis
Chen, Y.
Shen, T.
Ding, X.
BIOMED RESEARCH INTERNATIONAL, 2024, 2024
[27] RETRACTION: Long non-coding RNA receptor activator of nuclear factor-κB ligand promotes cisplatin resistance in non-small cell lung cancer cells (Retraction of Vol 21, art no 518, 2021)
Zhu, Zhongcheng
Gong, Xiaoyi
Li, Jing
Shi, Yufeng
Zhang, Mingyun
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2024, 28 (01)
[28] Exosomal Transfer of lncRNA H19 Promotes Erlotinib Resistance in Non-Small Cell Lung Cancer via miR-615-3p/ATG7 Axis
Pan, Rongtao
Zhou, Haiyan
CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 4283 - 4297
[29] RETRACTION: Statement of Retraction: The Lnc LINC00461/miR-30a-5p facilitates progression and malignancy in non-small cell lung cancer via regulating ZEB2 (Retraction of Vol 19, Pg 825, 2020)
Li, Xin
Liu, Minghui
Xia, Chunqiu
Zhao, Qingchun
CELL CYCLE, 2023, 22 (06) : 736 - 736
[30] RETRACTION: miR-3607-3p suppresses non-small cell lung cancer (NSCLC) by targeting TGFBR1 and CCNE2 (Retraction of Vol 17, art no E1007790, 2018)
Gao, P.
Wang, H.
Yu, J.
Zhang, J.
Yang, Z.
Liu, M.
PLOS GENETICS, 2024, 20 (05):

← 1 2 3 4 5 →